Primary care interval n= 10 493 | Diagnostic interval n= 12 929 | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | 25th centile | Median, days | 75th centile | % >60 days | % >90 days | n | 25th centile | Median, days | 75th centile | % >6 0 days | % >90 days | |
Total | 10 493 | 0 | 5 | 27 | 12.5 | 8.3 | 12 929 | 15 | 40 | 86 | 35.8 | 24 |
Male | 5478 | 0 | 8 | 30 | 13.7 | 9.2 | 6768 | 21 | 47 | 96 | 39.9 | 26.6 |
Female | 5015 | 0 | 1 | 21 | 11.2 | 7.3 | 6161 | 13 | 31 | 77 | 31.3 | 21.2 |
Age group, years | ||||||||||||
0–24 | 112 | 0 | 5 | 34.2 | 14.3 | 7.1 | 170 | 6.2 | 26.5 | 68.5 | 28.2 | 17.1 |
25–49 | 1131 | 0 | 0 | 20 | 10.9 | 8.2 | 1326 | 13 | 30 | 81 | 32.7 | 23.0 |
50–64 | 2485 | 0 | 4 | 28 | 13 | 8.6 | 2954 | 17 | 42 | 87 | 37 | 24.1 |
65–74 | 2989 | 0 | 7 | 29 | 13 | 9.1 | 3610 | 19 | 44 | 92 | 38.8 | 25.7 |
75–84 | 2693 | 0 | 5 | 27 | 12.6 | 8 | 3378 | 16 | 41 | 89 | 35.8 | 24.7 |
≥85 | 1083 | 0 | 5 | 24 | 11.1 | 6.6 | 1491 | 13 | 30 | 71 | 30 | 20.2 |
Cancer site | ||||||||||||
Bladder | 344 | 0 | 6 | 28 | 13.7 | 9.6 | 405 | 35 | 56 | 97 | 44.2 | 26.7 |
Brain | 85 | 0 | 3 | 19 | 12.9 | 9.4 | 221 | 10 | 29 | 67 | 27.1 | 16.7 |
Breast | 1399 | 0 | 0 | 0 | 2.6 | 2.1 | 1534 | 10 | 14 | 19 | 7.2 | 5.0 |
Cancer of unknown primary | 212 | 0 | 8 | 33 | 15.6 | 9 | 312 | 11.8 | 35 | 81.2 | 30.8 | 21.5 |
Colon | 773 | 0 | 6 | 29 | 14.9 | 10.7 | 1010 | 21 | 49 | 105 | 41.5 | 29.1 |
Endometrial | 317 | 0 | 0 | 14 | 7.6 | 6 | 335 | 14 | 34 | 86.5 | 34.3 | 23.9 |
Leukaemia | 253 | 0 | 6 | 26 | 11.5 | 6.7 | 340 | 6 | 30 | 82.5 | 32.6 | 23.8 |
Liver | 137 | 0 | 5 | 22 | 13.9 | 9.5 | 207 | 11 | 31 | 91 | 36.7 | 25.6 |
Lung | 1148 | 2 | 14 | 45.2 | 17.9 | 10.8 | 1748 | 20 | 43 | 86.2 | 38.5 | 23.5 |
Lymphoma | 473 | 0 | 11 | 35 | 14.8 | 9.3 | 581 | 23 | 50 | 100 | 41.1 | 27.7 |
Melanoma | 649 | 0 | 0 | 3 | 6 | 4.8 | 723 | 14 | 32 | 56 | 22.4 | 14.5 |
Multiple myeloma | 150 | 4.2 | 23.5 | 56.8 | 23.3 | 15.3 | 202 | 24 | 53.5 | 107.5 | 47.5 | 31.7 |
Oesophageal | 327 | 0 | 1 | 32 | 12.8 | 7.6 | 383 | 12 | 28 | 65.5 | 28.5 | 18.0 |
Oral/oropharyngeal | 158 | 0 | 1 | 27.2 | 15.2 | 7 | 189 | 17 | 39 | 74 | 33.9 | 20.1 |
Other | 999 | 0 | 7 | 32.5 | 13.7 | 8.9 | 1212 | 24 | 56 | 114.2 | 46.9 | 33.1 |
Ovarian | 240 | 0.8 | 13 | 28 | 9.6 | 6.2 | 285 | 29 | 55 | 85 | 45.6 | 22.8 |
Pancreatic | 303 | 1 | 11 | 36 | 14.5 | 9.2 | 386 | 15 | 42.5 | 93 | 37.3 | 26.4 |
Prostate | 1551 | 2 | 11 | 31.5 | 14.6 | 9.9 | 1678 | 29 | 55.5 | 126 | 46.4 | 33.4 |
Rectal | 455 | 0 | 1 | 22 | 14.3 | 10.5 | 496 | 21 | 42 | 88.2 | 34.7 | 24.6 |
Renal | 309 | 0 | 14 | 38 | 15.2 | 9.4 | 422 | 33.2 | 66 | 114 | 54.5 | 35.3 |
Stomach | 211 | 0 | 11 | 38 | 19.4 | 15.6 | 260 | 17 | 42 | 89.2 | 37.3 | 24.6 |
↵a Intervals are restricted to 0–730 days. Patients with a cancer diagnosed through screening are excluded. Primary Care Intervals and Diagnostic Intervals are available for patients where the relevant valid dates were entered. Any intervals that were not within 0–730 days were excluded.